These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8261451)

  • 1. Purification and characterization of a cell growth factor from a human leukemia cell line: immunological identity with ferritin.
    Kikyo N; Suda M; Kikyo N; Hagiwara K; Yasukawa K; Fujisawa M; Yazaki Y; Okabe T
    Cancer Res; 1994 Jan; 54(1):268-71. PubMed ID: 8261451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a cell growth factor from a human lung cancer cell line: its relationship with ferritin.
    Kikyo N; Hagiwara K; Fujisawa M; Kikyo N; Yazaki Y; Okabe T
    J Cell Physiol; 1994 Oct; 161(1):106-10. PubMed ID: 7929595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autocrine growth factor produced by a human promyelocytic leukemia cell line].
    Kasuga M; Yamanouchi T; Asano T; Tsushima T; Takaku F
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1410-5. PubMed ID: 3460526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor(s) produced by a human leukemic cell line growing in a protein-free chemically defined medium.
    Okabe T; Fujisawa M; Mihara A; Sato S; Fujiyoshi N; Takaku F
    Cancer Res; 1986 Mar; 46(3):1043-6. PubMed ID: 3455879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human myelomonocytic cell line THP-1 produces a novel growth-promoting factor with a wide target cell spectrum.
    Takeuchi A; Hayashi H; Naito Y; Baba T; Tamatani T; Onozaki K
    Cancer Res; 1993 Apr; 53(8):1871-6. PubMed ID: 8467508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cell growth-promoting factor identified in a B cell leukemia cell line, BALL-1.
    Dao T; Holán V; Minowada J
    Neoplasma; 1993; 40(5):265-73. PubMed ID: 8272154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the release of autocrine growth factor(s) by Hodgkin's cell lines.
    Imam SA; Taylor CR
    Anticancer Res; 1996; 16(4A):1727-32. PubMed ID: 8712691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.
    Seghezzi G; Marelli R; Mandriota SJ; Nolli ML; Mazzieri R; Mignatti P
    J Cell Physiol; 1996 Nov; 169(2):300-8. PubMed ID: 8908197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human acute leukemia-derived T-cell line produces two inhibitor factors which suppress lymphocyte proliferation: characterization and purification of the molecules.
    Montaldo PG; Lanciotti M; Castagnola E; Parodi MT; Cirillo C; Cornaglia-Ferraris P; Ponzoni M
    Lymphokine Res; 1988; 7(4):413-27. PubMed ID: 3210814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
    Nishi N; Ishikawa R; Inoue H; Nishikawa M; Kakeda M; Yoneya T; Tsumura H; Ohashi H; Yamaguchi Y; Motoki K; Sudo T; Mori KJ
    Exp Hematol; 1996 Sep; 24(11):1312-21. PubMed ID: 8862442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human erythrocyte-derived growth-promoting factor with a wide target cell spectrum: identification as catalase.
    Takeuchi A; Miyamoto T; Yamaji K; Masuho Y; Hayashi M; Hayashi H; Onozaki K
    Cancer Res; 1995 Apr; 55(7):1586-9. PubMed ID: 7882369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal amino acid sequence of leukemia derived growth factor (LGF) from human erythroleukemia cell culture.
    Mihara A; Fujiwara K; Sato S; Okabe T; Fujiyoshi N
    In Vitro Cell Dev Biol; 1987 Apr; 23(4):317-22. PubMed ID: 3032891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and biological properties of a cell growth-stimulating factor from Clostridium perfringens FERM P-14028.
    Watanabe K; Uesaka H; Sato K; Yamaguchi T; Awaya J
    Biochem Mol Biol Int; 1994 Oct; 34(4):645-52. PubMed ID: 7866289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of monkey liver ferritin.
    Sreeramulu D; Madhavan Nair K; Sivakumar B
    Indian J Biochem Biophys; 1996 Feb; 33(1):48-52. PubMed ID: 8744833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker.
    Cho YS; Lee YN; Cho-Chung YS
    Biochem Biophys Res Commun; 2000 Nov; 278(3):679-84. PubMed ID: 11095968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostatic growth factor, basic fibroblast growth factor, epidermal growth factor, and steroids on the proliferation of human fetal prostatic fibroblasts.
    Luo D; Lin Y; Liu X; Qin Z; Zhao C; Zhang Y; Yu Z
    Prostate; 1996 Jun; 28(6):352-8. PubMed ID: 8650071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of canine serum ferritin-binding proteins.
    Orino K; Uehara M; Okano S; Watanabe K
    Biometals; 2006 Jun; 19(3):315-22. PubMed ID: 16799869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
    EXS; 1993; 65():311-28. PubMed ID: 8380739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.